FDA Adverse Event Injury Summary report: N

UNKNOWN SILK SUTURE

MDR report key: 9346665 · Received November 20, 2019

Report

Report Number
9612501-2019-02238
Event Type
Injury
Date Received
November 20, 2019
Report Date
November 20, 2019
Manufacturer
DAVIS & GECK CARIBE LTD
Product Code
KOG
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
KS
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). TITLE: FEASIBILITY OF A NOVEL LAPAROSCOPIC TECHNIQUE WITH UNIDIRECTIONAL KNOTLESS BARED SUTURES FOR THE PRIMARY CLOSURE OF DUODENAL ULCER PERFORATION. SOURCE: SURGICAL ENDOSCOPY. 32 (3667-3674), 2018. DATE OF ONLINE PUBLICATION: 22 FEB 2018. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED. [(B)(4)].

Description of Event or Problem · 1

(B)(4): ACCORDING TO LITERATURE SOURCE OF STUDY PERFORMED, BETWEEN NOVEMBER 2009 AND OCTOBER 2015, THERE WERE 116 PATIENTS INCLUDED IN THE STUDY, 65 PATIENTS WERE TREATED WITH MULTIPLE SIMPLE CLOSURES UTILIZING BLACK SILK SUTURE AND REFERRED TO AS GROUP C WHICH PRESENTED THE FOLLOWING CASES; 5 FLUID COLLECTION, 3 STRICTURE AND 2 LEAKAGE. THE NASOGASTRIC TUBE WAS MAINTAINED UNTIL THE SECOND DAY AFTER SURGERY AND THEN REMOVED AFTER CONFIRMING THAT NO GASTRIC RETENTION WAS PRESENT. ON THE THIRD OR FOURTH POSTOPERATIVE DAY, ACCORDING TO THE DEGREE OF PERITONEAL INFLAMMATION AND SEVERITY OF INFECTION, RADIOCONTRAST UPPER GASTROINTESTINAL FLUOROSCOPY WAS PERFORMED TO DETECT SUTURE SITE LEAKAGE OR STRICTURE. THE DIET WAS ADVANCED ONLY AFTER THIS CONFIRMATION WAS MADE, AND INTRAVENOUS ANTIBIOTICS WERE DISCONTINUED AFTER INFECTIOUS PERITONITIS OR ANY RELATED INFECTIONS HAD RESOLVED. THE CLOSED DRAIN WAS REMOVED AFTER BODY FLUID ANALYSIS FOR AMYLASE AND BILIRUBIN; THE PATIENT WAS DISCHARGED WHEN AN ADVANCED DIET WAS TOLERATED WITHOUT COMPLICATION. THE UREA BREATH TEST (UBT) WAS PERFORMED IN ALL PATIENTS WITH A SUSPICION OF PERFORATED PEPTIC ULCER (PPU) AT THE TIME OF DIAGNOSIS IN THE EMERGENCY CENTER. ALL PATIENTS WHO UNDERWENT SURGERY RECEIVED PPI MEDICATION FOR 2 MONTHS, AND WHEN PATIENTS WERE UBT POSITIVE, A 2-WEEK COURSE OF TRIPLE THERAPY (PPI + CLARITHROMYCIN/METRONIDAZOLE + AMOXICILLIN) FOR HELICOBACTER PYLORI (HP) ERADICATION WAS STARTED BEFORE DISCHARGE. FOLLOW-UP ENDOSCOPY WITH A CAMPYLOBACTER-LIKE ORGANISM (CLO) TEST WAS PERFORMED IN ALL PATIENTS 3 MONTHS AFTER SURGERY. A 2-WEEK COURSE OF TRIPLE THERAPY WAS STARTED IN THOSE WHO SHOWED A POSITIVE CLO TEST, AND QUADRUPLE THERAPY WAS STARTED IN PATIENTS WHO SHOWED PERSISTENT POSITIVE CLO RESULTS AFTER TRIPLE THERAPY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1145226 UNKNOWN SILK SUTURE ENDOSCOPE AND/OR ACCESSORIES KOG DAVIS & GECK CARIBE LTD UNKNOWN SILK SUTURE

Patients

Seq Age Sex Outcome Treatment
1 61 YR Required Intervention